As the Director of Corporate Strategy & Partnerships at Harver, Marie Baldauf-Lenschen plays a pivotal role in shaping the company's strategic direction and fostering meaningful collaborations within the health tech landscape. With a robust background in machine learning (ML) and artificial intelligence (AI) innovation, Marie...
As the Director of Corporate Strategy & Partnerships at Harver, Marie Baldauf-Lenschen plays a pivotal role in shaping the company's strategic direction and fostering meaningful collaborations within the health tech landscape. With a robust background in machine learning (ML) and artificial intelligence (AI) innovation, Marie leverages her expertise to drive product innovation and strategy, ensuring that Harver remains at the forefront of technological advancements in the industry. Her passion for building inclusive and ethical algorithms resonates deeply with her commitment to using data to facilitate behavior change, particularly in the context of health tech applications.
In her current role, Marie is instrumental in developing and executing Harver's corporate strategy, focusing on strategic negotiations and partnership development that align with the company's mission to enhance health outcomes through innovative technology. Her adeptness in project management methodologies, including Scrum and Kanban, allows her to lead cross-functional teams effectively, ensuring that key projects are delivered on time and within scope. Marie's analytical skills enable her to conduct thorough research and data analysis, providing valuable insights that inform strategic decisions and drive growth.
Key projects under her leadership include the integration of advanced ML algorithms into Harver's platform, enhancing user experience and operational efficiency. By fostering partnerships with other tech innovators and health organizations, Marie is not only expanding Harver's market reach but also contributing to the broader dialogue on ethical AI in health tech. Her unique blend of product strategy, research and development, and a deep understanding of the health tech ecosystem positions her as a thought leader in the industry, dedicated to creating impactful solutions that prioritize both innovation and inclusivity.
